Component

Propylcobalamin

Synthetic straight-chain C3 alkylcobalamin used as an experimental dealkylation probe; not a physiological dietary coenzyme.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Fibroblasts from three cblC patients had little or no conversion of cobalt-57-labeled propylcobalamin into adenosylcobalamin and methylcobalamin, whereas control skin fibroblasts converted the probe.

    Human MMACHC gene → Propylcobalamin source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    false
    evidence_location
    Abstract; indexed Methods: Assessment of dealkylation; Discussion
    experimental_model
    Human control and cblC patient fibroblast labeling
    exposure
    0.125 nM cobalt-57 propylcobalamin for 48 hours
    limitations
    Propylcobalamin is a synthetic C3 probe; patients and genotypes differ and this comparison does not quantify every natural vitamer response.
    nutrient_topic
    Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
    organism
    Homo sapiens
    plain_language
    A synthetic B12 probe exposed the processing defect in patient cells.
    primary_references
    [hannibal-2009-cell-processing] Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product (2009). https://pubmed.ncbi.nlm.nih.gov/19447654/ DOI: 10.1016/j.ymgme.2009.04.005
    tissue_or_cell_type
    Skin fibroblasts
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 809–821

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human control and cblC patient fibroblast labeling · source_derived_draft · unverified_draft

    ### b12-cblc-propyl-probe Fibroblasts from three cblC patients had little or no conversion of cobalt-57-labeled propylcobalamin into adenosylcobalamin and methylcobalamin, whereas control skin fibroblasts converted the probe. Condition category: machinery_impairment nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A synthetic B12 probe exposed the processing defect in patient cells. organism: Homo sapiens tissue_or_cell_type: Skin fibroblasts experimental_model: Human control and cblC patient fibroblast labeling limitations: Propylcobalamin is a synthetic C3 probe; patients and genotypes differ and this comparison does not quantify every natural vitamer response. exposure: 0.125 nM cobalt-57 propylcobalamin for 48 hours cross_nutrient: false evidence_location: Abstract; indexed Methods: Assessment of dealkylation; Discussion [hannibal-2009-cell-processing] Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product (2009). https://pubmed.ncbi.nlm.nih.gov/19447654/ DOI: 10.1016/j.ymgme.2009.04.005
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards